Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8157460rdf:typepubmed:Citationlld:pubmed
pubmed-article:8157460lifeskim:mentionsumls-concept:C1553378lld:lifeskim
pubmed-article:8157460lifeskim:mentionsumls-concept:C0011750lld:lifeskim
pubmed-article:8157460lifeskim:mentionsumls-concept:C0039421lld:lifeskim
pubmed-article:8157460lifeskim:mentionsumls-concept:C0042210lld:lifeskim
pubmed-article:8157460lifeskim:mentionsumls-concept:C0596545lld:lifeskim
pubmed-article:8157460lifeskim:mentionsumls-concept:C1705822lld:lifeskim
pubmed-article:8157460lifeskim:mentionsumls-concept:C0348011lld:lifeskim
pubmed-article:8157460pubmed:issue1lld:pubmed
pubmed-article:8157460pubmed:dateCreated1994-5-16lld:pubmed
pubmed-article:8157460pubmed:abstractTextTechnological advances by developed countries are producing safer, more potent vaccines. In addition, the transfer of the technology of vaccine production to some developing countries has been taking place during the past five decades, thereby making possible the participation of developing countries in the production and supply of the essential biologicals that are required for immunization programs. Examples of successful transfers of technology, the decisive elements and factors that contribute to the transfers, and the major obstacles to such transfers are presented.lld:pubmed
pubmed-article:8157460pubmed:languageenglld:pubmed
pubmed-article:8157460pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8157460pubmed:citationSubsetIMlld:pubmed
pubmed-article:8157460pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8157460pubmed:statusMEDLINElld:pubmed
pubmed-article:8157460pubmed:issn0266-4623lld:pubmed
pubmed-article:8157460pubmed:authorpubmed-author:HommaAAlld:pubmed
pubmed-article:8157460pubmed:authorpubmed-author:KnoussR FRFlld:pubmed
pubmed-article:8157460pubmed:issnTypePrintlld:pubmed
pubmed-article:8157460pubmed:volume10lld:pubmed
pubmed-article:8157460pubmed:ownerNLMlld:pubmed
pubmed-article:8157460pubmed:authorsCompleteYlld:pubmed
pubmed-article:8157460pubmed:pagination47-54lld:pubmed
pubmed-article:8157460pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:8157460pubmed:meshHeadingpubmed-meshheading:8157460-...lld:pubmed
pubmed-article:8157460pubmed:meshHeadingpubmed-meshheading:8157460-...lld:pubmed
pubmed-article:8157460pubmed:meshHeadingpubmed-meshheading:8157460-...lld:pubmed
pubmed-article:8157460pubmed:meshHeadingpubmed-meshheading:8157460-...lld:pubmed
pubmed-article:8157460pubmed:meshHeadingpubmed-meshheading:8157460-...lld:pubmed
pubmed-article:8157460pubmed:meshHeadingpubmed-meshheading:8157460-...lld:pubmed
pubmed-article:8157460pubmed:meshHeadingpubmed-meshheading:8157460-...lld:pubmed
pubmed-article:8157460pubmed:meshHeadingpubmed-meshheading:8157460-...lld:pubmed
pubmed-article:8157460pubmed:meshHeadingpubmed-meshheading:8157460-...lld:pubmed
pubmed-article:8157460pubmed:meshHeadingpubmed-meshheading:8157460-...lld:pubmed
pubmed-article:8157460pubmed:meshHeadingpubmed-meshheading:8157460-...lld:pubmed
pubmed-article:8157460pubmed:meshHeadingpubmed-meshheading:8157460-...lld:pubmed
pubmed-article:8157460pubmed:year1994lld:pubmed
pubmed-article:8157460pubmed:articleTitleThe transfer of vaccine technology to developing countries. The Latin American experience.lld:pubmed
pubmed-article:8157460pubmed:publicationTypeJournal Articlelld:pubmed